Add description, images, menus and links to your mega menu
A column with no settings can be used as a spacer
Link to your collections, sales and even external links
Add up to five columns
Add description, images, menus and links to your mega menu
A column with no settings can be used as a spacer
Link to your collections, sales and even external links
Add up to five columns
August 20, 2022 5 min read
The difference between full-spectrum and broad-spectrum CBD is the compound they contain. CBD is called full-spectrum CBD when its product contains several naturally occurring cannabis plant extracts such as terpenes and other cannabinoids. Full-spectrum CBD is derived from the hemp plant and contains other cannabinoids. There are over 100 cannabinoids, including CBD and THC. Both are responsible for the therapeutic and psychoactive effects of cannabis products. CBD does not cause impairment, while THC has intoxicating effects. Cannabis also has over 150 terpenes affecting the plant's fragrance. The other compound of the cannabis plant is flavonoids, over twenty different types. They include vegetables, fruits, and grains, among others.
The article gives you a comparison between Full-spectrum and broad-spectrum CBD and the isolate type and their benefits.
The difference is that while full-spectrum CBD products contain small THC, broad-spectrum and isolate are from THC. Broad-spectrum removes the THC component but keeps the other cannabinoids, flavonoids, and terpenes. Isolate removes everything except CBD.
CBD can be beneficial to humans. CBD therapeutic effects are stronger when combined with other cannabis compounds, including flavonoids, terpenes, and lesser-lesser known as cannabinoids. Broad-spectrum CBD does not have other compounds, but the THC found in full-spectrum products can amp up the anti-inflammatory and pain-relieving benefits (O'Brien, 2022).
Full-spectrum CBD is popular. It is easy to find full-spectrum CBD products like topicals, edibles, sublingual, and pills.
Not all users may want THC in their CBD products. You can choose to avoid it, or you might worry about showing up for a drug test. Depending on the outcome, this is possible, especially if you buy mislabeled CBD products and have more THC.
Some products in this article are derived from hemp; the plants contain less than 0.3% THC. Hemp-derived CBD products that contain less than 0.3 percent THC are federally legal, but they are illegal in some state laws.
These are a few great full-spectrum CBD products to get you started. The products meet specific list safety, transparency criteria, and quality. The products are:
CBG or cannabigerol is one of more than 100 cannabinoids found in the hemp cannabis plant. CBG is chemically different from THC, and the chances of cannabinoids causing you to fail a drug test are minimal. CBG is extracted from hemp, and it has been traced for THC, less than 0.3 percent weight. Take 10 – 20 mg of CBG an hour before bed to help your body unwind. This allowance enables the body to feel the effects. Take more if you don't feel the effects.
Using CBG in the form of an isolated cannabinoid does not show up in a drug test screening because testing panels don't look for cannabigerol.
CBG relieves pain, has the intoxicating effect of cannabinoids like THC, and has therapeutic effects (Russo, 2011). CBG can be found useful in animals for the following therapeutic benefits.
Hryhorowicz et al. (2021) discovered the beneficial effects of CBG on inflammatory bowel disease. The study above discovered that inflammatory bowel disease is a condition causing chronic inflammation in the animal bowel.
Weigelt et al.(2021) discovered that CBG has therapeutic potential for the treatment of glaucoma. The study above discovered CBG in cats with glaucoma and noticed a reduction in eye pressure and fluid produced by the eye, maintaining eye pressure and providing nutrition for the eye.
Borrelli et al. (2014) observed the effects of CBG on rats with colon cancer. The observations showed promise in blocking the receptors that cause cancer cell growth. The study above suggested that CBG should be considered translationally curing and preventing colon cancer.
Cannabinol (CBN) is a natural chemical compound in a cannabis plant. Cannabinoids interact with the body system. CBN is derived from the hemp plant since the plant is legal in the United States. Hemp plants produce a low CBN, manipulated to create more CBN for extraction. The different types of CBN products are:
CBN and CBG are both subject to differences because of their sources. CBG is legal according to federal laws and in several states because it comes from young hemp plants. According to the 2018 firm bill, the production and sale of commercial hemp and all hemp products are also defined as a cannabis plant that contains less than 0.3 % THC by weight.
Hemp is legal, making the CBG products derived from hemp legal without restriction. CBN can also be made legally from hemp. Ensure you order the products from the companies that are exclusively hemp-derived CBN. Some companies produce CBN by exposing THC to UV light. Such products are considered marijuana-derived. Products that are made from marijuana are illegal federally and in many countries.
Both are cannabinoids providing users with positive effects, and you have to choose what is good for you. CBG has energizing, invigorating, and concentration boosting effects, as many CBN users report sleepiness and sleep (Evans, 2020). CBG seems to be a better option if you are interested in using non-psychoactive cannabinoids to increase mental acuity.
CDB can cause side effects and interact with other medications that one may be taking and cause other effects. You must purchase CBD products from a well-reputed dispensary and consult a doctor before taking the products. Products from hemp seed and CBD do not cause high because the level of THC is usually very low. CBD and hemp products have potential health benefits, but researchers are trying to discover more about them.
Borrelli, F., Pagano, E., Romano, B., Panzera, S., Maiello, F., Coppola, D., ... & Izzo, A. A. (2014). Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid. Carcinogenesis, 35(12), 2787-2797.
Evans, J. (2020). The Ultimate Guide to CBD: Explore the World of Cannabidiol. Fair Winds Press.
O'Brien, K. (2022). Cannabidiol (CBD) in Cancer Management. Cancers, 14(4), 885.
Hryhorowicz, S., Kaczmarek-Ryś, M., Zielińska, A., Scott, R. J., Słomski, R., & Pławski, A. (2021). Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease–A Systematic Review. Frontiers in immunology, 12.
Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects. British journal of pharmacology, 163(7), 1344-1364.
Weigelt, M. A., Sivamani, R., & Lev‐Tov, H. (2021). The therapeutic potential of cannabinoids for integumentary wound management. Experimental dermatology, 30(2), 201-211.
Enter our weekly prize draw to win cool prizes from our store!